I-Mab Announces IND Approval for Its Proprietary TJC4, A Potentially Differentiated CD47 Antibody, to Initiate Clinical Trials in China Jul 16, 2019 Life Science
Invitae to Acquire Jungla to Advance Genetic Variant Interpretation, Adds Supplemental RNA Analysis to Deliver Deeper, More Informative Results to Patients Jul 12, 2019 Life Science
AblaCare Announces Series A Financing of €10 Million by Sofinnova Partners for Innovative Infertility Treatment and Appoints Jodie Fam as CEO Jul 10, 2019 Life Science
U.S. Judge Strikes Down Trump Administration Rule Requiring Drug Prices in TV Ads Jul 9, 2019 Life Science
Grifols Announces FDA Approval of Xembify®, 20% Subcutaneous Immunoglobulin for Primary Immunodeficiencies Jul 6, 2019 Life Science
